Ken Griffin’s LeonaBio Inc LONA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-33,987
Closed -$141K 12623
2025
Q3
$141K Buy
33,987
+12,974
+62% +$50.9K ﹤0.01% 11580
2025
Q2
$63.5K Buy
21,013
+16,056
+324% +$45.5K ﹤0.01% 11651
2025
Q1
$14.1K Buy
+4,957
New +$22K ﹤0.01% 13378
2024
Q3
Sell
-5,335
Closed -$125K 14211
2024
Q2
$141K Sell
5,335
-5,476
-51% -$129K ﹤0.01% 10428
2024
Q1
$296K Sell
10,811
-198
-2% -$6.28K ﹤0.01% 9477
2023
Q4
$268K Sell
11,009
-341
-3% -$6.05K ﹤0.01% 9383
2023
Q3
$229K Sell
11,350
-10,149
-47% -$260K ﹤0.01% 9652
2023
Q2
$634K Sell
21,499
-28,937
-57% -$824K ﹤0.01% 7415
2023
Q1
$1.26M Sell
50,436
-7,951
-14% -$256K ﹤0.01% 6292
2022
Q4
$1.85M Buy
58,387
+14,309
+32% +$451K ﹤0.01% 5628
2022
Q3
$1.31M Sell
44,078
-40,821
-48% -$1.41M ﹤0.01% 6421
2022
Q2
$2.59M Buy
84,899
+14,810
+21% +$1.36M ﹤0.01% 5032
2022
Q1
$9.46M Sell
70,089
-6,215
-8% -$655K ﹤0.01% 3033
2021
Q4
$9.94M Sell
76,304
-37,251
-33% -$4.71M ﹤0.01% 3088
2021
Q3
$10.7M Sell
113,555
-6,116
-5% -$623K ﹤0.01% 2973
2021
Q2
$12.3M Sell
119,671
-6,636
-5% -$1.16M ﹤0.01% 2769
2021
Q1
$23.2M Buy
126,307
+10,191
+9% +$2.25M 0.01% 1775
2020
Q4
$39.8M Buy
116,116
+8,314
+8% +$1.96M 0.01% 1143
2020
Q3
$19.9M Buy
+107,802
New +$18M 0.01% 1573

Other funds holding LONA

Ken Griffin's LONA Position: Q4 2025 in Review

Ken Griffin sold out of LeonaBio Inc (LONA) in Q4 2025, closing a stake of 33,987 shares — an estimated $141K sold.

Ken Griffin first reported a position in LONA in Q3 2020 and held it in 19 quarters. The position peaked at $39.8M in Q4 2020. 42 funds tracked by Wall St. Rank hold LONA as of Q4 2025.

  • Ken Griffin reported no remaining LeonaBio Inc position as of Q4 2025 after selling out during the quarter.
  • Ken Griffin sold 33,987 LeonaBio Inc shares in Q4 2025, an estimated $141K.
  • Ken Griffin first reported a position in LeonaBio Inc in Q3 2020 and held it in 19 quarters.
  • Ken Griffin's LeonaBio Inc position peaked at $39.8M in Q4 2020.
  • 42 funds tracked by Wall St. Rank held LeonaBio Inc as of Q4 2025.

Based on Citadel Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.